Principal Investigator
Frances Valdes
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20240095
Clinical Trial Summary
A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1310 in Subjects with Advanced/Metastatic Solid Tumors
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Breast Cancer
Contact Information
Phone Number
305-243-2647